Risks of myeloid malignancies in patients with autoimmune conditions
| dc.contributor.author | Anderson, L. A. | |
| dc.contributor.author | Pfeiffer, R. M. | |
| dc.contributor.author | Landgren, O. | |
| dc.contributor.author | Gadalla, S. | |
| dc.contributor.author | Berndt, S. I. | |
| dc.contributor.author | Engels, E. A. | |
| dc.date.accessioned | 2025-05-15T08:38:01Z | |
| dc.date.available | 2025-05-15T08:38:01Z | |
| dc.date.issued | 2009-03-10 | |
| dc.description | This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, Centers for Medicare and Medicaid Services; Information Management Services, Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare database. This research was supported by the Intramural Research Program of the National Cancer Institute. The Research and Development Office, Northern Ireland, funded Dr Lesley Anderson to participate in the Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute. The authors thank Winnie Ricker and Ruth Parsons, Information Management Services, Rockville, MD for constructing the dataset, and Joan Warren, Division of Cancer Control and Population Sciences, National Cancer Institute, MD, for her assistance with the SEER-Medicare dataset. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 7 | |
| dc.format.extent | 150608 | |
| dc.identifier | 159625056 | |
| dc.identifier | c1fb82bc-6f1f-466f-94fd-1993e7520113 | |
| dc.identifier | 61749100610 | |
| dc.identifier | 19259097 | |
| dc.identifier.citation | Anderson, L A, Pfeiffer, R M, Landgren, O, Gadalla, S, Berndt, S I & Engels, E A 2009, 'Risks of myeloid malignancies in patients with autoimmune conditions', British Journal of Cancer, vol. 100, no. 5, pp. 822-828. https://doi.org/10.1038/sj.bjc.6604935 | en |
| dc.identifier.doi | 10.1038/sj.bjc.6604935 | |
| dc.identifier.iss | 5 | en |
| dc.identifier.issn | 0007-0920 | |
| dc.identifier.other | ORCID: /0000-0002-1000-3649/work/72175501 | |
| dc.identifier.uri | https://hdl.handle.net/2164/25461 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=61749100610&partnerID=8YFLogxK | en |
| dc.identifier.vol | 100 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | British Journal of Cancer | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Autoimmune conditions | en |
| dc.subject | Chronic myeloproliferative diseases | en |
| dc.subject | Myelodysplastic syndrome | en |
| dc.subject | Myeloid leukaemia | en |
| dc.subject | R Medicine | en |
| dc.subject | Oncology | en |
| dc.subject | Cancer Research | en |
| dc.subject.lcc | R | en |
| dc.title | Risks of myeloid malignancies in patients with autoimmune conditions | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Anderson_etal_BJC_Risks_Of_Myeloid_VOR.pdf
- Size:
- 147.08 KB
- Format:
- Adobe Portable Document Format
